Chronic Spontaneous Urticaria in Hong Kong: Clinical Characteristics, Real-World Practice and Implications for COVID-19 Vaccination
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic Spontaneous Urticaria in Hong Kong: Clinical Characteristics, Real-World Practice and Implications for COVID-19 Vaccination
Authors
Keywords
-
Journal
Allergy Asthma & Immunology Research
Volume 15, Issue 1, Pages 32
Publisher
The Korean Academy of Asthma, Allergy and Clinical Immunology and The Korean Academy of Pediatric Al
Online
2023-01-18
DOI
10.4168/aair.2023.15.1.32
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria
- (2022) Weiru Yuan et al. Dermatologic Therapy
- Updated consensus statements on COVID-19 Vaccine Allergy Safety in Hong Kong
- (2022) Valerie Chiang et al. Asia Pacific Allergy
- The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria
- (2021) T. Zuberbier et al. ALLERGY
- Forewarned is Forearmed: chronic spontaneous urticaria as a potential risk to effective SARS‐COV‐2 vaccine uptake and global public health
- (2021) W.H. Bermingham et al. BRITISH JOURNAL OF DERMATOLOGY
- Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
- (2021) Mark W. Tenforde et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong – Clinical outcomes, barriers to vaccination, and urgency for reform
- (2021) Valerie Chiang et al. World Allergy Organization Journal
- Cost–utility analysis comparing hospital‐based intravenous immunoglobulin with home‐based subcutaneous immunoglobulin in patients with secondary immunodeficiency
- (2019) Tanja M. Windegger et al. VOX SANGUINIS
- Classification of hypersensitivity reactions
- (2019) Melanie C. Dispenza ALLERGY AND ASTHMA PROCEEDINGS
- Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU
- (2018) G. Sussman et al. ALLERGY
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
- (2018) T. Zuberbier et al. ALLERGY
- Cost-effectiveness of omalizumab for the treatment of chronic spontaneous urticaria
- (2018) T.A. Kanters et al. BRITISH JOURNAL OF DERMATOLOGY
- Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review
- (2018) Kanokvalai Kulthanan et al. Journal of Allergy and Clinical Immunology-In Practice
- Efficacy and safety of omalizumab in Japanese and Korean patients with refractory chronic spontaneous urticaria
- (2017) Michihiro Hide et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study
- (2017) Bo Ri Kim et al. JOURNAL OF DERMATOLOGY
- Corticosteroid-related toxicity in patients with chronic idiopathic urticaria‐chronic spontaneous urticaria
- (2016) Dennis Ledford et al. ALLERGY AND ASTHMA PROCEEDINGS
- Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
- (2016) Zuo-Tao Zhao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- BSACI guideline for the management of chronic urticaria and angioedema
- (2015) R. J. Powell et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study
- (2015) Sarbjit S. Saini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study
- (2013) H. Zhong et al. ALLERGY
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
- (2013) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria
- (2011) Sarbjit Saini et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Risk of first-generation H1-antihistamines: a GA2LEN position paper
- (2010) M. K. Church et al. ALLERGY
- Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1
- (2010) M. Maurer et al. ALLERGY
- Development of a daily diary for patients with chronic idiopathic urticaria
- (2010) Susan D. Mathias et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- How to assess disease activity in patients with chronic urticaria?
- (2008) A. Młynek et al. ALLERGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started